Literature DB >> 24521782

Vaccination with leptospiral outer membrane lipoprotein LipL32 reduces kidney invasion of Leptospira interrogans serovar canicola in hamsters.

P C Humphryes1, M E Weeks, M AbuOun, G Thomson, A Núñez, N G Coldham.   

Abstract

The Leptospira interrogans vaccines currently available are serovar specific and require regular booster immunizations to maintain protection of the host. In addition, a hamster challenge batch potency test is necessary to evaluate these vaccines prior to market release, requiring the use of a large number of animals, which is ethically and financially undesirable. Our previous work showed that the N terminus of the outer membrane protein LipL32 was altered in Leptospira interrogans serovar Canicola vaccines that fail the hamster challenge test, suggesting that it may be involved in the protective immune response. The aim of this study was to determine if vaccination with LipL32 protein alone could provide a protective response against challenge with L. interrogans serovar Canicola to hamsters. Recombinant LipL32, purified from an Escherichia coli expression system, was assessed for protective immunity in five groups of hamsters (n = 5) following a challenge with the virulent L. interrogans serovar Canicola strain Kito as a challenge strain. However, no significant survival against the L. interrogans serovar Canicola challenge was observed compared to that of unvaccinated negative controls. Subsequent histological analysis revealed reduced amounts of L. interrogans in the kidneys from the hamsters vaccinated with recombinant LipL32 protein prior to challenge; however, no significant survival against the L. interrogans serovar Canicola challenge was observed compared to that of unvaccinated negative controls. This finding corresponded to a noticeably reduced severity of renal lesions. This study provides evidence that LipL32 is involved in the protective response against L. interrogans serovar Canicola in hamsters and is the first reported link to LipL32-induced protection against kidney invasion.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24521782      PMCID: PMC3993109          DOI: 10.1128/CVI.00719-13

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  21 in total

Review 1.  Leptospirosis: a zoonotic disease of global importance.

Authors:  Ajay R Bharti; Jarlath E Nally; Jessica N Ricaldi; Michael A Matthias; Monica M Diaz; Michael A Lovett; Paul N Levett; Robert H Gilman; Michael R Willig; Eduardo Gotuzzo; Joseph M Vinetz
Journal:  Lancet Infect Dis       Date:  2003-12       Impact factor: 25.071

2.  Duration of immunity in dogs vaccinated against leptospirosis with a bivalent inactivated vaccine.

Authors:  H L B M Klaasen; M J C H Molkenboer; M P Vrijenhoek; M J Kaashoek
Journal:  Vet Microbiol       Date:  2003-08-29       Impact factor: 3.293

3.  Surfaceome of Leptospira spp.

Authors:  Paul A Cullen; Xiaoyi Xu; James Matsunaga; Yolanda Sanchez; Albert I Ko; David A Haake; Ben Adler
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

Review 4.  Pathogenesis of leptospirosis: the influence of genomics.

Authors:  Ben Adler; Miranda Lo; Torsten Seemann; Gerald L Murray
Journal:  Vet Microbiol       Date:  2011-03-05       Impact factor: 3.293

5.  Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein 1.

Authors:  C Branger; B Chatrenet; A Gauvrit; F Aviat; A Aubert; J M Bach; G André-Fontaine
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

6.  Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection.

Authors:  Raghavan U M Palaniappan; Sean P McDonough; Thomas J Divers; Chia-Sui Chen; Ming-Jeng Pan; Mitsuharu Matsumoto; Yung-Fu Chang
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

7.  Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge.

Authors:  Fabiana Kömmling Seixas; Everton Fagonde da Silva; Daiane Drawanz Hartwig; Gustavo Maia Cerqueira; Marta Amaral; Michel Quevedo Fagundes; Robson Grando Dossa; Odir Antônio Dellagostin
Journal:  Vaccine       Date:  2007-11-12       Impact factor: 3.641

Review 8.  Leptospira and leptospirosis.

Authors:  Ben Adler; Alejandro de la Peña Moctezuma
Journal:  Vet Microbiol       Date:  2009-03-13       Impact factor: 3.293

9.  Evaluation of different ways of presenting LipL32 to the immune system with the aim of developing a recombinant vaccine against leptospirosis.

Authors:  Fabiana Kömmling Seixas; Claudia Hartleben Fernandes; Daiane Drawanz Hartwig; Fabricio Rochedo Conceição; José Antônio Guimarães Aleixo; Odir Antônio Dellagostin
Journal:  Can J Microbiol       Date:  2007-04       Impact factor: 2.419

10.  Protection against lethal leptospirosis after vaccination with LipL32 coupled or coadministered with the B subunit of Escherichia coli heat-labile enterotoxin.

Authors:  André A Grassmann; Samuel R Félix; Carolina Ximendes dos Santos; Marta G Amaral; Amilton C P Seixas Neto; Michel Q Fagundes; Fabiana K Seixas; Everton F da Silva; Fabricio R Conceição; Odir A Dellagostin
Journal:  Clin Vaccine Immunol       Date:  2012-02-29
View more
  7 in total

1.  Identification of Leptospiral Protein Antigens Recognized by WC1+ γδ T Cell Subsets as Target for Development of Recombinant Vaccines.

Authors:  Aline F Teixeira; Alexandria Gillespie; Alehegne Yirsaw; Emily Britton; Janice C Telfer; Ana Lucia Tabet Oller Nascimento; Cynthia L Baldwin
Journal:  Infect Immun       Date:  2021-10-25       Impact factor: 3.609

2.  Leptospiral outer membrane protein LipL32 induces inflammation and kidney injury in zebrafish larvae.

Authors:  Ming-Yang Chang; Yi-Chuan Cheng; Shen-Hsing Hsu; Tsu-Lin Ma; Li-Fang Chou; Hsiang-Hao Hsu; Ya-Chung Tian; Yung-Chang Chen; Yuh-Ju Sun; Cheng-Chieh Hung; Rong-Long Pan; Chih-Wei Yang
Journal:  Sci Rep       Date:  2016-06-09       Impact factor: 4.379

3.  Immunoprotective properties of recombinant LigA and LigB in a hamster model of acute leptospirosis.

Authors:  Karen V Evangelista; Kristel Lourdault; James Matsunaga; David A Haake
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

4.  Evaluation of Lsa46 and Lsa77 Leptospiral Proteins for Their Immunoprotective Activities in Hamster Model of Leptospirosis.

Authors:  Aline F Teixeira; Luis G V Fernandes; Antonio Souza Filho; Gisele O Souza; Silvio A Vasconcellos; Marcos B Heinemann; Ana L T O Nascimento
Journal:  Biomed Res Int       Date:  2018-06-10       Impact factor: 3.411

5.  A live attenuated-vaccine model confers cross-protective immunity against different species of the Leptospira genus.

Authors:  Elsio A Wunder; Haritha Adhikarla; Camila Hamond; Katharine A Owers Bonner; Li Liang; Camila B Rodrigues; Vimla Bisht; Jarlath E Nally; David P Alt; Mitermayer G Reis; Peter J Diggle; Philip L Felgner; Albert Ko
Journal:  Elife       Date:  2021-01-26       Impact factor: 8.140

6.  The leptospiral LipL21 and LipL41 proteins exhibit a broad spectrum of interactions with host cell components.

Authors: 
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

Review 7.  Recent advances in canine leptospirosis: focus on vaccine development.

Authors:  Henricus Lbm Eric Klaasen; Ben Adler
Journal:  Vet Med (Auckl)       Date:  2015-06-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.